Fibroscan 502 instructions for use

    • [PDF File]By Dee rapposelli

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_2e2c10.html

      The FibroScan 502 Touch device (EchoSens and Sandhill Scientific), including the M+ and XL probes, received 510(k) clearance from the US Food and Drug Adminis-tration on April 5th, 2013 and is ready to be marketed in the United States. FibroScan 502 Touch is the first device to use quantitative elastography in patients with liver

    • Fibroscan and its Relation to Insulin Resistance

      performed with Fibroscan (echosens- France) 502 M probe, it was performed by experienced operators following the instructions of the manufacturer, expressing the stiffness results in Kilopascals (kPa). All measurements were performed with FibroScan (M) probe or (XL) probe. Hepatic steatosis is

    • 578 Original Article Analysis of liver steatosis analysis ...

      FibroScan with an M probe (Echosens, FibroScan 502, France) was used to measure CAP. The attenuation of ultrasound propagation in the liver tissue is increased by fat accumulation. Therefore, the detection of ultrasonic attenuation coefficient is a quantitative method for evaluating the degree of liver steatosis (10). Both LiSA and

    • [PDF File]The comparison of resting metabolic rate between biopsy ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_3ebcaf.html

      Fibroscan Examinations All the Fibroscan examinations were performed using Fibroscan 502 touch device following the manufacturer’s instructions (Echosens SA, Paris, France) by a single operator (YY). The examinations were started with M probe. The probe was switched to XL following the automatic

    • [PDF File]FibroScan 502 Touch

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_8a2cfb.html

      USe The FirST-in-claSS elaSTography Based on patented Vibration- controlled Transient elastography (VcTe™), FibroScan® 502 Touch provides multiple controls for reliable, accurate and reproducible assessment of liver tissue stiffness: controlled vibration, controlled energy, controlled algorithm. → VcTe™ guidance process ensures

    • [PDF File]Operator training requirements and diagnostic accuracy of ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_2573d6.html

      Fibroscan 502 machine (Echosens, France). The manufacturer recommends that the XL-probe should be used in patients with a skin-liver capsule distance >2.5 cm (measured by sonographic imaging). Due to the time constraints in liver clinic, operators were advised to use the XL-probe in patients with a measured

    • [PDF File]User Manual for myFibroScan V2 - ECHOSENS

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_418969.html

      All specific indications, intended use, target population and precautions for use are described in the user manual dedicated to FAST score product (ref. E505M001). 3.5.1. Inputs screen By clicking on the “FAST score” block, the user accesses to the FAST input screen (figure 4). The user can fill CAP (Controlled Attenuation

    • [PDF File]Feasibility study and reference values of FibroScan 502 ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_e30527.html

      FibroScan 502 with M probe in healthy preschool children aged 5 years Jing Zeng 1 , Xi Zhang 2 , Chao Sun 1 , Qin Pan 1 , Wen-Yi Lu 3 , Qian Chen 4 , Li-Su Huang 2* and Jian-Gao Fan 5*

    • [PDF File]Prevalence of steatosis and fibrosis in young adults in ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_03101e.html

      assessment by transient elastography (FibroScan 502 Touch; Echosens, Paris, France), with measurement of controlled attenuation parameter (CAP), as standardised non-invasive measures for assessment of fibrosis and quantification of steatosis in NAFLD.10,16 Study data were Research in context Evidence before this study

    • [PDF File]FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_a5c8f2.html

      LSM and CAP values detected by FibroScan We quantified LSM and CAP values using FibroScan 502 to assess the degree of fatty liver or liver fibrosis in CHB patients. According to the Operator’s instructions, patients with CAP scores $237.7 db/m were defined as fatty liver patients, in which237.7–259.3db/mwas definedas mild fatty

    • [PDF File]THE WOMEN’S INTERAGENCY HIV STUDY SECTION 41: FIBROSCAN ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_cc4007.html

      The new FDA-approved Fibroscan® 502 Touch device includes both a medium (M) probe and an extra-large (XL) probe, which will allow for acquisition of valid scans in women with high BMI. The overall goal of the LIVRA study is to define the contribution of HIV, HCV, the

    • [PDF File]Childhood Liver Disease Research Network (ChiLDReN)

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_8312fb.html

      5. FibroScan™ LSM results can differentiate children with ALGS or A1AT with clinical features of portal hypertension from those without. 6. FibroScan-based LSM will correlate with serum biomarkers of fibrosis. 7. FibroScan-based assessment of LSM in children with A1AT and ALGS will reliably reveal increases over 2 years of follow- up.

    • [PDF File]FieldPoint Operating Instructions FP-CTR-502 and cFP-CTR-502

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_2bd628.html

      These operating instructions describe how to install and use the National Instruments FP-CTR-502 and cFP-CTR-502 counter modules (referred to inclusively as the [c]FP-CTR-502). For information about configuring and accessing the [c]FP-CTR-502 over a network, refer to the user manual for the FieldPoint network module you are using. Features The ...

    • [PDF File]Principal Boston MedTech Advisors Inc. - Food and Drug ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_9942f8.html

      FibroScan® 502 Touch model of the FibroScan® Family of Products. Recognized Consensus Standards Used Non-clinical testing to assure compliance with acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic and mechanical safety

    • [PDF File]Prognostic impact of liver fibrosis and steatosis by ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_248791.html

      data, with the Fibroscan 502 equipment (Echosens, ® France), according to the instructions and training pro-vided by the manufacturer [23]. All the measures were acquired with either the 3.5 MHz standard M probe or the 2.5 MHz standard XL probe (whenever there were unsuccessful measurements with the M probe). Measure -

    • [PDF File]Justification for Using Fibroscan

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_abc336.html

      of the fibrosis (fibrosis staging). The proper use of shear wave velocity analysis requires control of various physical parameters to ensure an accurate, reliable and reproducible assessment of the tissue stiffness, all novel features incorporated into FibroScan 502 Touch device. The stiffer the liver, the more severe the fibrosis.

    • [PDF File]POWERED BY vCtE InnovatIon in liver disease management

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_46b5e9.html

      Based on patented Vibration-Controlled Transient elastography (VCTe™), FibroScan® 502 Touch provides multiple controls for reliable, accurate and reproducible assessment of liver tissue stiffness: controlled vibration, controlled energy, controlled algorithm. → VCTe guidance process ensures the operator obtains measurements of the liver

    • [PDF File]POWERED BY VCTe The first clinically validated device ...

      https://info.5y1.org/fibroscan-502-instructions-for-use_1_168aa4.html

      USe The FirST-in-claSS elaSTography Based on patented Vibration- controlled Transient elastography (VcTe™), FibroScan® 502 provides multiple controls for reliable, accurate and reproducible assessment of liver tissue stiffness: controlled vibration, controlled energy, controlled algorithm. → VcTe™ guidance process ensures

    • Fibroscan - AASLD

      Figure 1 FibroScan 502 Touch. Adapted from Echosens. Figure 2 The FibroScan Transducer and Vibrator. Adapted from Echosens. REVIEW Patel and Wilder Fibroscan 98 Clinical Liver Disease, Vol 4, No 5, November 2014 An Official Learning Resource of AASLD

Nearby & related entries:

To fulfill the demand for quickly locating and searching documents.

It is intelligent file search solution for home and business.

Literature Lottery

Advertisement
Hot searches

©2024 5y1.org, Inc. All rights reserved.